Patient Symptoms Are Better Measure Of Decongestant’s Efficacy – FDA
This article was originally published in The Tan Sheet
Executive Summary
The patient self-assessed nasal congestion symptom score, not nasal air resistance, is the preferred tool to evaluate the effectiveness of an oral nasal decongestant such as phenylephrine, according to a report by a division of FDA's Office of New Drugs